APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemical Drug and Biologic Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chemical Drug and Biologic Drug Market Outlook and Growth Opportunities 2026

21 December 2025202 pages

Choose your research edition.

Industry ResearchChemical Drug and Biologic Drug Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemical Drug and Biologic Drug Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Chemical Drug and Biologic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemical Drug and Biologic Drug Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemical Drug and Biologic Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Chemical Drug and Biologic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chemical Drug and Biologic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chemical Drug and Biologic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chemical Drug and Biologic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chemical Drug and Biologic Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chemical Drug and Biologic Drug market include Takeda, Teva, Sanofi, Johnson & Johnson, Novartis, Novo Nordisk, Merck & Co., Roche and Eli Lilly & Co., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Chemical Drug and Biologic Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chemical Drug and Biologic Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chemical Drug and Biologic Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chemical Drug and Biologic Drug market.

Chemical Drug and Biologic Drug Segment by Company

Takeda

Teva

Sanofi

Johnson & Johnson

Novartis

Novo Nordisk

Merck & Co.

Roche

Eli Lilly & Co.

Pfizer

GlaxoSmithKline

Biogen

Bayer

Bristol Myers Squibb

Amgen

AbbVie

AstraZeneca

Gilead Sciences

Boehringer Ingelheim

Astellas

Chemical Drug and Biologic Drug Segment by Type

Chemical Drug

Biologic Drug

Chemical Drug and Biologic Drug Segment by Application

Hospital

Retail Pharmacy

Other

Chemical Drug and Biologic Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chemical Drug and Biologic Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Chemical Drug and Biologic Drug key companies, revenue, market share, and recent developments.

3. To split the Chemical Drug and Biologic Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Chemical Drug and Biologic Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chemical Drug and Biologic Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Chemical Drug and Biologic Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemical Drug and Biologic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemical Drug and Biologic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemical Drug and Biologic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chemical Drug and Biologic Drug industry.

Chapter 3: Detailed analysis of Chemical Drug and Biologic Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Chemical Drug and Biologic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Chemical Drug and Biologic Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chemical Drug and Biologic Drug Industry Trends Table 2. Chemical Drug and Biologic Drug Industry Drivers Table 3. Chemical Drug and Biologic Drug Industry Opportunities and Challenges Table 4. Chemical Drug and Biologic Drug Industry Restraints Table 5. Global Chemical Drug and Biologic Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chemical Drug and Biologic Drug Revenue Share by Company (2021-2026) Table 7. Global Chemical Drug and Biologic Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Chemical Drug and Biologic Drug Key Company Manufacturing Base & Headquarters Table 9. Global Chemical Drug and Biologic Drug Company, Product Type & Application Table 10. Global Chemical Drug and Biologic Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Chemical Drug and Biologic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chemical Drug Table 15. Significant Companies of Biologic Drug Table 16. Global Chemical Drug and Biologic Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Chemical Drug and Biologic Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Chemical Drug and Biologic Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Chemical Drug and Biologic Drug Sales Value Share by Type (2021-2026) Table 20. Global Chemical Drug and Biologic Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Retail Pharmacy Table 23. Significant Companies of Other Table 24. Global Chemical Drug and Biologic Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Chemical Drug and Biologic Drug Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Chemical Drug and Biologic Drug Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Chemical Drug and Biologic Drug Sales Value Share by Application (2021-2026) Table 28. Global Chemical Drug and Biologic Drug Sales Value Share by Application (2027-2032) Table 29. Global Chemical Drug and Biologic Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Chemical Drug and Biologic Drug Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Chemical Drug and Biologic Drug Sales Value Share by Region (2021-2026) Table 32. Global Chemical Drug and Biologic Drug Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Chemical Drug and Biologic Drug Sales Value Share by Region (2027-2032) Table 34. Global Chemical Drug and Biologic Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Chemical Drug and Biologic Drug Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Chemical Drug and Biologic Drug Sales Value Market Share by Country (2021-2026) Table 37. Global Chemical Drug and Biologic Drug Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Chemical Drug and Biologic Drug Sales Value Market Share by Country (2027-2032) Table 39. Takeda Company Information Table 40. Takeda Business Overview Table 41. Takeda Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Takeda Chemical Drug and Biologic Drug Product Portfolio Table 43. Takeda Recent Development Table 44. Teva Company Information Table 45. Teva Business Overview Table 46. Teva Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Teva Chemical Drug and Biologic Drug Product Portfolio Table 48. Teva Recent Development Table 49. Sanofi Company Information Table 50. Sanofi Business Overview Table 51. Sanofi Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Sanofi Chemical Drug and Biologic Drug Product Portfolio Table 53. Sanofi Recent Development Table 54. Johnson & Johnson Company Information Table 55. Johnson & Johnson Business Overview Table 56. Johnson & Johnson Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Johnson & Johnson Chemical Drug and Biologic Drug Product Portfolio Table 58. Johnson & Johnson Recent Development Table 59. Novartis Company Information Table 60. Novartis Business Overview Table 61. Novartis Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Novartis Chemical Drug and Biologic Drug Product Portfolio Table 63. Novartis Recent Development Table 64. Novo Nordisk Company Information Table 65. Novo Nordisk Business Overview Table 66. Novo Nordisk Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Novo Nordisk Chemical Drug and Biologic Drug Product Portfolio Table 68. Novo Nordisk Recent Development Table 69. Merck & Co. Company Information Table 70. Merck & Co. Business Overview Table 71. Merck & Co. Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck & Co. Chemical Drug and Biologic Drug Product Portfolio Table 73. Merck & Co. Recent Development Table 74. Roche Company Information Table 75. Roche Business Overview Table 76. Roche Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Roche Chemical Drug and Biologic Drug Product Portfolio Table 78. Roche Recent Development Table 79. Eli Lilly & Co. Company Information Table 80. Eli Lilly & Co. Business Overview Table 81. Eli Lilly & Co. Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Eli Lilly & Co. Chemical Drug and Biologic Drug Product Portfolio Table 83. Eli Lilly & Co. Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Chemical Drug and Biologic Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Chemical Drug and Biologic Drug Product Portfolio Table 88. Pfizer Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Chemical Drug and Biologic Drug Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Biogen Company Information Table 95. Biogen Business Overview Table 96. Biogen Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Biogen Chemical Drug and Biologic Drug Product Portfolio Table 98. Biogen Recent Development Table 99. Bayer Company Information Table 100. Bayer Business Overview Table 101. Bayer Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Bayer Chemical Drug and Biologic Drug Product Portfolio Table 103. Bayer Recent Development Table 104. Bristol Myers Squibb Company Information Table 105. Bristol Myers Squibb Business Overview Table 106. Bristol Myers Squibb Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Bristol Myers Squibb Chemical Drug and Biologic Drug Product Portfolio Table 108. Bristol Myers Squibb Recent Development Table 109. Amgen Company Information Table 110. Amgen Business Overview Table 111. Amgen Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Amgen Chemical Drug and Biologic Drug Product Portfolio Table 113. Amgen Recent Development Table 114. AbbVie Company Information Table 115. AbbVie Business Overview Table 116. AbbVie Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. AbbVie Chemical Drug and Biologic Drug Product Portfolio Table 118. AbbVie Recent Development Table 119. AstraZeneca Company Information Table 120. AstraZeneca Business Overview Table 121. AstraZeneca Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. AstraZeneca Chemical Drug and Biologic Drug Product Portfolio Table 123. AstraZeneca Recent Development Table 124. Gilead Sciences Company Information Table 125. Gilead Sciences Business Overview Table 126. Gilead Sciences Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Gilead Sciences Chemical Drug and Biologic Drug Product Portfolio Table 128. Gilead Sciences Recent Development Table 129. Boehringer Ingelheim Company Information Table 130. Boehringer Ingelheim Business Overview Table 131. Boehringer Ingelheim Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Boehringer Ingelheim Chemical Drug and Biologic Drug Product Portfolio Table 133. Boehringer Ingelheim Recent Development Table 134. Astellas Company Information Table 135. Astellas Business Overview Table 136. Astellas Chemical Drug and Biologic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Astellas Chemical Drug and Biologic Drug Product Portfolio Table 138. Astellas Recent Development Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Chemical Drug and Biologic Drug Product Image Figure 2. Global Chemical Drug and Biologic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chemical Drug and Biologic Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Chemical Drug and Biologic Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chemical Drug Image Figure 8. Biologic Drug Image Figure 9. Global Chemical Drug and Biologic Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Chemical Drug and Biologic Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Chemical Drug and Biologic Drug Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Retail Pharmacy Image Figure 14. Other Image Figure 15. Global Chemical Drug and Biologic Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Chemical Drug and Biologic Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Chemical Drug and Biologic Drug Sales Value Share by Application (2021-2032) Figure 18. Global Chemical Drug and Biologic Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Chemical Drug and Biologic Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Chemical Drug and Biologic Drug Sales Value (2021-2032) & (US$ Million) Figure 21. North America Chemical Drug and Biologic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Chemical Drug and Biologic Drug Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Chemical Drug and Biologic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Chemical Drug and Biologic Drug Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Chemical Drug and Biologic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Chemical Drug and Biologic Drug Sales Value (2021-2032) & (US$ Million) Figure 27. South America Chemical Drug and Biologic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Chemical Drug and Biologic Drug Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Chemical Drug and Biologic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Drug
  • Biologic Drug
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Novo Nordisk
  • Merck & Co.
  • Roche
  • Eli Lilly & Co.
  • Pfizer
  • GlaxoSmithKline
  • Biogen
  • Bayer
  • Bristol Myers Squibb
  • Amgen
  • AbbVie
  • AstraZeneca
  • Gilead Sciences
  • Boehringer Ingelheim
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chemical Drug and Biologic Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chemical Drug and Biologic Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Chemical Drug and Biologic Drug Market Dynamics
  1. 2.1 Chemical Drug and Biologic Drug Industry Trends
  2. 2.2 Chemical Drug and Biologic Drug Industry Drivers
  3. 2.3 Chemical Drug and Biologic Drug Industry Opportunities and Challenges
  4. 2.4 Chemical Drug and Biologic Drug Industry Restraints
3 Chemical Drug and Biologic Drug Market by Company
  1. 3.1 Global Chemical Drug and Biologic Drug Company Revenue Ranking in 2025
  2. 3.2 Global Chemical Drug and Biologic Drug Revenue by Company (2021-2026)
  3. 3.3 Global Chemical Drug and Biologic Drug Company Ranking (2024-2026)
  4. 3.4 Global Chemical Drug and Biologic Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Chemical Drug and Biologic Drug Company Product Type and Application
  6. 3.6 Global Chemical Drug and Biologic Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Chemical Drug and Biologic Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Chemical Drug and Biologic Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Chemical Drug and Biologic Drug Market by Type
  1. 4.1 Chemical Drug and Biologic Drug Type Introduction
  2. 4.1.1 Chemical Drug
  3. 4.1.2 Biologic Drug
  4. 4.2 Global Chemical Drug and Biologic Drug Sales Value by Type
  5. 4.2.1 Global Chemical Drug and Biologic Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chemical Drug and Biologic Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Chemical Drug and Biologic Drug Sales Value Share by Type (2021-2032)
5 Chemical Drug and Biologic Drug Market by Application
  1. 5.1 Chemical Drug and Biologic Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Chemical Drug and Biologic Drug Sales Value by Application
  6. 5.2.1 Global Chemical Drug and Biologic Drug Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chemical Drug and Biologic Drug Sales Value by Application (2021-2032)
  8. 5.2.3 Global Chemical Drug and Biologic Drug Sales Value Share by Application (2021-2032)
6 Chemical Drug and Biologic Drug Regional Value Analysis
  1. 6.1 Global Chemical Drug and Biologic Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chemical Drug and Biologic Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Chemical Drug and Biologic Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Chemical Drug and Biologic Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chemical Drug and Biologic Drug Sales Value (2021-2032)
  7. 6.3.2 North America Chemical Drug and Biologic Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Chemical Drug and Biologic Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Chemical Drug and Biologic Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Chemical Drug and Biologic Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Chemical Drug and Biologic Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Chemical Drug and Biologic Drug Sales Value (2021-2032)
  16. 6.6.2 South America Chemical Drug and Biologic Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Chemical Drug and Biologic Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Chemical Drug and Biologic Drug Sales Value Share by Country, 2025 VS 2032
7 Chemical Drug and Biologic Drug Country-level Value Analysis
  1. 7.1 Global Chemical Drug and Biologic Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chemical Drug and Biologic Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Chemical Drug and Biologic Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Chemical Drug and Biologic Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Chemical Drug and Biologic Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Chemical Drug and Biologic Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Chemical Drug and Biologic Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Chemical Drug and Biologic Drug Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Chemical Drug and Biologic Drug Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Chemical Drug and Biologic Drug Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Chemical Drug and Biologic Drug Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Chemical Drug and Biologic Drug Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Novo Nordisk
  32. 8.6.1 Novo Nordisk Company Information
  33. 8.6.2 Novo Nordisk Business Overview
  34. 8.6.3 Novo Nordisk Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novo Nordisk Chemical Drug and Biologic Drug Product Portfolio
  36. 8.6.5 Novo Nordisk Recent Developments
  37. 8.7 Merck & Co.
  38. 8.7.1 Merck & Co. Company Information
  39. 8.7.2 Merck & Co. Business Overview
  40. 8.7.3 Merck & Co. Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck & Co. Chemical Drug and Biologic Drug Product Portfolio
  42. 8.7.5 Merck & Co. Recent Developments
  43. 8.8 Roche
  44. 8.8.1 Roche Company Information
  45. 8.8.2 Roche Business Overview
  46. 8.8.3 Roche Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Chemical Drug and Biologic Drug Product Portfolio
  48. 8.8.5 Roche Recent Developments
  49. 8.9 Eli Lilly & Co.
  50. 8.9.1 Eli Lilly & Co. Company Information
  51. 8.9.2 Eli Lilly & Co. Business Overview
  52. 8.9.3 Eli Lilly & Co. Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eli Lilly & Co. Chemical Drug and Biologic Drug Product Portfolio
  54. 8.9.5 Eli Lilly & Co. Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Chemical Drug and Biologic Drug Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 GlaxoSmithKline
  62. 8.11.1 GlaxoSmithKline Company Information
  63. 8.11.2 GlaxoSmithKline Business Overview
  64. 8.11.3 GlaxoSmithKline Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GlaxoSmithKline Chemical Drug and Biologic Drug Product Portfolio
  66. 8.11.5 GlaxoSmithKline Recent Developments
  67. 8.12 Biogen
  68. 8.12.1 Biogen Company Information
  69. 8.12.2 Biogen Business Overview
  70. 8.12.3 Biogen Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biogen Chemical Drug and Biologic Drug Product Portfolio
  72. 8.12.5 Biogen Recent Developments
  73. 8.13 Bayer
  74. 8.13.1 Bayer Company Information
  75. 8.13.2 Bayer Business Overview
  76. 8.13.3 Bayer Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bayer Chemical Drug and Biologic Drug Product Portfolio
  78. 8.13.5 Bayer Recent Developments
  79. 8.14 Bristol Myers Squibb
  80. 8.14.1 Bristol Myers Squibb Company Information
  81. 8.14.2 Bristol Myers Squibb Business Overview
  82. 8.14.3 Bristol Myers Squibb Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bristol Myers Squibb Chemical Drug and Biologic Drug Product Portfolio
  84. 8.14.5 Bristol Myers Squibb Recent Developments
  85. 8.15 Amgen
  86. 8.15.1 Amgen Company Information
  87. 8.15.2 Amgen Business Overview
  88. 8.15.3 Amgen Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Amgen Chemical Drug and Biologic Drug Product Portfolio
  90. 8.15.5 Amgen Recent Developments
  91. 8.16 AbbVie
  92. 8.16.1 AbbVie Company Information
  93. 8.16.2 AbbVie Business Overview
  94. 8.16.3 AbbVie Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AbbVie Chemical Drug and Biologic Drug Product Portfolio
  96. 8.16.5 AbbVie Recent Developments
  97. 8.17 AstraZeneca
  98. 8.17.1 AstraZeneca Company Information
  99. 8.17.2 AstraZeneca Business Overview
  100. 8.17.3 AstraZeneca Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  101. 8.17.4 AstraZeneca Chemical Drug and Biologic Drug Product Portfolio
  102. 8.17.5 AstraZeneca Recent Developments
  103. 8.18 Gilead Sciences
  104. 8.18.1 Gilead Sciences Company Information
  105. 8.18.2 Gilead Sciences Business Overview
  106. 8.18.3 Gilead Sciences Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Gilead Sciences Chemical Drug and Biologic Drug Product Portfolio
  108. 8.18.5 Gilead Sciences Recent Developments
  109. 8.19 Boehringer Ingelheim
  110. 8.19.1 Boehringer Ingelheim Company Information
  111. 8.19.2 Boehringer Ingelheim Business Overview
  112. 8.19.3 Boehringer Ingelheim Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Boehringer Ingelheim Chemical Drug and Biologic Drug Product Portfolio
  114. 8.19.5 Boehringer Ingelheim Recent Developments
  115. 8.20 Astellas
  116. 8.20.1 Astellas Company Information
  117. 8.20.2 Astellas Business Overview
  118. 8.20.3 Astellas Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Astellas Chemical Drug and Biologic Drug Product Portfolio
  120. 8.20.5 Astellas Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst